Highlights
ASX: TLX       TELIX PHARMACEUTICALS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
1.33   -0.04 (2.92%)  1.305 - 1.37  516,925

Overview

 
Avg Volume (4 weeks):657,737
4 Weeks Range:1.30 - 1.71
4 Weeks Price Volatility (%):
7.32%
52 Weeks Range:0.54 - 1.775
52 Weeks Price Volatility (%):
63.97%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on development and commercialization of diagnostic and therapeutic products based on radiopharmaceuticals, or molecularly-targeted radiation (MTR). MTR is a novel therapeutic approach that selectively delivers radiation to cells that exhibit certain molecular profiles or targets that may be indicative of cancer. The Company's MTR products such as TLX-250 diagnosis and treatment of renal (kidney), TLX-591 treatment of metastatic castrate-resistant prostate cancer, and TLX-101 treatment of glioblastoma (brain cancer).

  Be the first to like this.
 


 

575  581  696  9327 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ADN 0.058+0.008 
 MSE 0.017-0.002 
 ANL 0.0030.00 
 AMP 1.78+0.045 
 CLZ 0.0020.00 
 WCNOE 0.002+0.001 
 TLS 3.770.00 
 GTEOA 0.004+0.002 
 NVO 0.012+0.001 
 AZY 0.014-0.003 
Partners & Brokers